Chapel Hill R&D Tax Credit Benefits for Businesses

R&D Tax Credits for Chapel Hill, North Carolina Businesses

Chapel Hill, North Carolina, is known for industries such as healthcare, education, technology, retail, and biotechnology. Top companies in the city include UNC Health Care, a leading healthcare provider; the University of North Carolina at Chapel Hill, a major educational institution; SAS Institute, a significant technology employer; Eastgate Shopping Center, a key player in the retail sector; and BioAgilytix, a prominent biotechnology company. The R&D Tax Credit can help these industries save on taxes by encouraging innovation and technological advancements.

find out more

Are you eligible?

Why choose us?

Pass an Audit?

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed’s office location at 6255 Towncenter Drive, Clemmons, North Carolina is less than 90 miles away from Chapel Hill and provides R&D tax credit consulting and advisory services to Chapel Hill and the surrounding areas such as: Raleigh, Durham, Greensboro, Winston-Salem and Fayetteville.

If you have any questions or need further assistance, please call or email our local North Carolina Partner on (984) 480-4601.
Feel free to book a quick teleconference with one of our North Carolina R&D tax credit specialists at a time that is convenient for you. Click here for more information about R&D tax credit management and implementation.

Schedule a Teleconference

Chapel Hill, North Carolina Patent of the Year – 2024/2025

Renovion Inc. has been awarded the 2024/2025 Patent of the Year for its groundbreaking work in respiratory therapeutics. Their invention, detailed in U.S. Patent No. 11890315, titled ‘Stable ascorbic acid compositions and methods of using same’, introduces a novel formulation designed to enhance respiratory health by stabilizing key antioxidant compounds.

This patented composition combines ascorbic acid (vitamin C), glutathione or its derivatives, and bicarbonate in precise molar ratios. The formulation addresses the longstanding challenge of maintaining the stability of ascorbic acid, which is prone to degradation. By stabilizing these antioxidants, the composition ensures effective delivery and prolonged shelf life.

Designed for therapeutic use, this innovation holds promise for treating pulmonary or airway viral infections. The stabilized antioxidants can help reduce inflammation and oxidative stress in the respiratory tract, potentially improving outcomes for patients with chronic respiratory conditions.

Renovion’s advancement offers a practical solution to a critical need in respiratory care. By enhancing the stability and efficacy of antioxidant therapies, this invention could lead to more effective treatments for respiratory diseases, benefiting patients and healthcare providers alike.